Klea Holding SA (EPA:ALKLH)

Market Cap	56.67M +6.7%
Revenue (ttm)	22.17M +28.4%
Net Income	2.28M +62.3%
EPS	0.01 +84.6%
Shares Out	306.99M
PE Ratio	26.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	279,201
Open	0.1834
Previous Close	0.1810
Day's Range	0.1792 - 0.1880
52-Week Range	0.1534 - 0.3075
Beta	-0.47
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 19, 2026

About Klea Holding

Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, Saudi Arabia, and the European Union. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. Additionally, the company engages in the production of pharmaceuticals. The company was formerly known as Visiomed Group SA and changed its name to Klea Holding SA in June 2024. Klea Holding ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2007
• Employees: 128
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALKLH

Financial Performance

In 2025, Klea Holding's revenue was 22.17 million, an increase of 28.42% compared to the previous year's 17.26 million. Earnings were 2.28 million, an increase of 62.35%.